About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« Could Alice Be Used to Invalidate Diehr? Of Course It Could | Main | Peach Genome Dissected to Provide Insights into Ecological Influences »

April 21, 2021


"Sen. Tillis argued that the '... development of new capacity... requires... the vaccine originator companies... to transfer not just patents but specific know-how.'"

This is correct. The proposed waiver---by itself---would be a mere empty gesture. Somehow, the implications of that observation lead Sen. Tillis in a very different direction than they lead me.

"[Sen. Tillis'] letter states that... the waiver would not be an efficient means of creating new global manufacturing capacity."

Once again, correct. The waiver is virtue signaling, nothing more.

"According to Sen. Tillis, "[t]his means that foreign nations... can demand any technology with the loosest connection to COVID without recourse."

Well, yes, anyone *can* "demand" anything that they want to demand. That does not mean that we have to give it to them, but we cannot stop them from "demanding."

"Sen. Tillis contends that the waiver's main impact would be to legitimatize the transfer of American technologies[*] to foreign competitors..."

How? The waiver does not compel the U.S. to do anything, much less individual companies that are headquartered in the U.S.

* Off topic, but merely for my interest and education, what exactly is an "American technology"? How do we recognize which technologies are "American" and which are not?

The comments to this entry are closed.

May 2024

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31